Navigation Links
Myriant to Participate in U.S. DOE Biomass 2013 Conference
Date:7/29/2013

Quincy, MA (PRWEB) July 29, 2013

Myriant Corporation today announced that Sue Hager, Myriant’s Senior Vice President of Corporate Communications and Government Affairs, will participate in the U.S. Department of Energy (DOE) Event, Biomass 2013: How the Advanced Bioindustry is Reshaping American Energy. Ms. Hager will present as part of the Conference’s opening plenary session titled “Celebrating Successes ? The Foundation of an Advanced Bioindustry,” on Wednesday, July 31st, 2013, from 10:10 a.m. ? 11:30 p.m. EST. The Biomass 2013 Conference will take place at the Washington, D.C. Convention Center.

About Myriant Corporation
Myriant is a global leader innovating and commercializing bio-based chemical intermediates. Myriant enables its customers to achieve their sustainability initiatives by utilizing renewable feedstocks to produce high-value, cost-advantaged chemicals, including bio-succinic acid and its derivatives. Myriant is currently commercializing its bio-succinic acid platform from two operating chemical plants: The first is Myriant's flagship plant in Lake Providence, LA; the other, a commercial validation facility located in Leuna, Germany, which is operated by Myriant's global partner, ThyssenKrupp Uhde. Myriant, together with Johnson Matthey - Davy Technologies (JM Davy), combined the efficiencies of their respective chemical processes for the production of cost-competitive bio-BDO and bio-THF made from Myriant's bio-succinic acid, yielding overall carbon efficiency of 87%. Myriant is also advancing its proprietary, low-cost, high-purity process for bio-acrylic acid. Myriant is a 2013 Red Herring Top 100 Company in North America. More information about Myriant's pipeline of renewable chemicals can be found at http://www.myriant.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10956087.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
2. ViroPharma to Participate in Two December Healthcare Investor Conferences
3. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
4. Medical Experts Who Participated in CSL Behrings Key Issues Dialogue Prefer Albumin for Fluid Management
5. Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
6. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
7. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
8. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
9. AVANIR Pharmaceuticals To participate in two conferences in March
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. ViroPharma To Participate In Two May Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), today ... CEO, Jim Joyce . In a ... Bill Gates warned world leaders that a ... weapons. Mr. Gates expressed his concern, which is also ... terrorists have access to the necessary tools to design ...
(Date:2/24/2017)... , Feb. 24, 2017  Driven by ... biotechnology are now the fastest growing categories, finds ... Specialty Actives in Personal Care: Multi-regional Market Analysis ... and management consulting firm Kline. "Biotechnology ... that make them more effective for skin and ...
(Date:2/24/2017)... , ... February 24, 2017 , ... FireflySci, Inc is ... in late 2014, FireflySci had the goal of bringing their powerful cuvette ... to shape the path that FireflySci is going on as they add yet another ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
Breaking Biology Technology:
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):